Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medpace Holdings, Inc. Director's Dealing 2018

Oct 1, 2018

30442_dirs_2018-10-01_f2f306c7-bc34-49ac-9f8a-ce6df42e3cc3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2018-09-28

Reporting Person: Troendle August J. (Director, President & CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-09-28 Common Stock J 748459 $59.91 Disposed 8147051 Indirect
2018-09-28 Common Stock J 251851 $59.91 Acquired 603702 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 10000 Indirect

Footnotes

F1: Represents distributions of MEDP shares in-kind to the holders of Medpace Investors, LLC's ("MPI") Incentive Units.

F2: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the shares held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

F3: Represents the receipt of the allocable portion of shares in the distribution by MPI as more fully described in Footnote 1.